NBC Securities’s Aurinia Pharmaceuticals AUPH Stock Holding History

NBC Securities’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-600	Closed	-$3K	–	2124
2024 Q2	$3K	Hold	600	–	–	﹤0.01%	1922
2024 Q1	$3K	Buy	+600	New	+$4.07K	﹤0.01%	1929

Other funds holding AUPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

NBC Securities's AUPH Position: Q3 2024 in Review

NBC Securities sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2024, closing a stake of 600 shares — an estimated $3K sold.

NBC Securities first reported a position in AUPH in Q1 2024 and held it in 2 quarters. The position peaked at $3K in Q2 2024. 183 funds tracked by Wall St. Rank hold AUPH as of Q3 2024.

NBC Securities reported no remaining Aurinia Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
NBC Securities sold 600 Aurinia Pharmaceuticals shares in Q3 2024, an estimated $3K.
NBC Securities first reported a position in Aurinia Pharmaceuticals in Q1 2024 and held it in 2 quarters.
NBC Securities's Aurinia Pharmaceuticals position peaked at $3K in Q2 2024.
183 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2024.

Based on NBC Securities's 13F filing for Q3 2024, filed 15 Oct 2024.